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Abstract
© 2016, Springer Science+Business Media New York.Alcoholic liver disease is a huge medical
and  social  problem  that  leads  to  liver  fibrosis,  cirrhosis,  and  hepatocellular  carcinoma.
Unfortunately,  the last  stages of  the disease do not have efficient treatment,  except liver
transplantation, and require development of new therapeutical approaches. Transplantation of
stem cells might be the most promising approach. In our research, we studied transplantation of
autologous hematopoietic stem cells (HSC) into the celiac trunk of patients with alcoholic liver
cirrhosis.  In  this  article,  we  pay  particular  attention  to  proliferation  and  apoptosis—two
fundamental  processes,  which determine the fate  of  regeneration.  Liver  biopsy specimens
before  treatment,  3  and  12  months  after  transplantation  of  HSC,  were  stained
immunohistochemically  with  antibodies  against  PCNA  and  Bcl-2.  The  results  showed  that
treatment was safe and effective, hepatocytes increased proliferation, and inflammatory cells
decreased antiapoptotic activity, signifying improvement in liver regeneration. However, effect
of treatment after 12 months decreases and requires repeated HSC transplantation.
http://dx.doi.org/10.1007/s12668-016-0354-2
Keywords
Alcoholic liver disease, Hematopoietic stem cells, Liver cirrhosis, Liver fibrosis, Regeneration,
Transplantation
References
[1] Fujii, H., Hirose, T., Oe, S., et al. (2002). Contribution of bone marrow cells to liver regeneration after partial
hepatectomy in mice. J Hepatol, 36(5), 653–659.
[2] Masson, S., Harrison, D. J., Plevvris, J. N., Newsome, P. H. (2004). Potential of hematopoietic stem cell therapy
in hepatology: a critical review. Stem cells, 22(6), 897–907.
[3] Kakinuma, S., Tanaka, Y., Chinzei, R., et al. (2003). Human umbilical cord blood as a source of transplantable
hepatic progenitor cells. Stem Cells, 21(2), 217–227.
[4] Tang, X. P., Yang, X., Tan, H., Ding, Y. L., Zhang, M., Wang, W. L. (2003). Clinical and experimental study on
therapeutic effect of umbilical cord blood transplantation on severe viral hepatitis. World J. Gastroenterol, 9(9),
1999–2003.
[5] Am Esch, J. S., II, Knoefel, W. T., Klein, M., et al. (2005). Portal application of autologous CD133+ bone marrow
cells to the liver: a novel concept to support hepatic regeneration. Stem Cells, 23(4), 463–470.
[6] Am Esch, J. S., II, Schmelzle, M., Fürst, G., et al. (2012). Infusion of CD133+ bone marrow-derived stem cells
after  selective  portal  vein  embolization  enhances  functional  hepatic  reserves  after  extended  right
hepatectomy: a retrospective single-center study. Ann. Surg, 255(1), 79–85.
[7] Saadeh, S., Cammel, G., Carey, W. D., Younossi, Z., Barnes, D., Easley, K. (2001). The role of liver biopsy in
chronic hepatitis C. Hepatology, 33(1), 196–200.
[8] Leonardi, E., Girlando, S., Serio, G., Mauri, F. A., Perrone, G., Scampini, S., et al.  (1992). PCNA and Ki67
expression  in  breast  carcinoma:  correlations  with  clinical  and  biological  variables.  J  Clin.  Pathol,  45(5),
416–419.
[9] Vaux, D. L., Cory, S., Adams, J. M. (1988). Bcl-2 gene promotes haemopoietic cell survival and cooperates with
c-myc to immortalize pre-B cells. Nature, 335, 440–442.
[10] Kim, J. K., Park, Y. N., Kim, J. S., et al. (2010). Autologous bone marrow infusion activates the progenitor cell
compartment in patients with advanced liver cirrhosis. Cell Transplant, 19(10), 1237–1246.
[11] Terai, S., Sakaida, I., Yamamoto, N., et al. (2003). An in vivo model for monitoring transdifferentiation of bone
marrow cells into functional hepatocytes. J. Biochem, 134(4), 551–558.
